by Scott Nelson
Learn from the brightest CEOs in medtech and healthtech. That's our primary goal with Medsider. We unpack the strategies, tactics, and secrets behind the most successful startups. Join tens of thousands of ambitious doers and get access to the top medical device and health technology thought leaders.
Language
🇺🇲
Publishing Since
2/5/2013
Email Addresses
1 available
Phone Numbers
0 available
April 16, 2025
<p>In this episode of <a href="https://medsider.com/interviews">Medsider Radio</a>, we sat down with <a href="https://www.linkedin.com/in/randy-pritchard/">Randy Pritchard</a> and <a href="https://www.linkedin.com/in/erica-rogers-bb93a97/">Erica Rogers</a>, leaders of <a href="https://axenahealth.com/">Axena Health</a>. Axena is transforming pelvic floor therapy with <a href="https://levacares.com/">Leva</a>, a device bringing clinically-proven, supervised pelvic floor muscle training into women’s homes. </p><p>Randy, CEO of Axena, brings nearly 25 years of healthcare experience to the company, most recently as CEO of Pillar Biosciences and previously holding leadership positions at Roche Diagnostics, where he spent 18 years developing commercial expertise. Erica, who sits on Axena's Board of Directors, spent a decade as President and CEO of Silk Road Medical, leading the company from early clinical trials through IPO and eventual acquisition by Boston Scientific. A returning guest to the podcast after nearly half a decade, Erica previously held roles at Medicine360, co-founded two other medical device companies, and spent over 12 years at Boston Scientific prior to her role at Silk Road.</p><p>In this interview, they share essential medtech commercialization insights: identify your specific patient segment, build continuous clinical evidence, and communicate consistently with investors. Their experience offers invaluable lessons for medical device entrepreneurs navigating today's complex healthcare landscape.</p><p>Before we dive into the discussion, I wanted to mention a few things:</p><p>First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to <a href="https://medsider.com/">Medsider.com</a> and sign up for our free newsletter.</p><p>Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a <a href="https://medsider.com/subscribe">Medsider premium membership</a>. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!</p><p>We recently introduced some fantastic additions exclusively for Medsider premium members, including <a href="https://medsider.com/playbooks">playbooks</a>, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and <a href="https://medsider.com/investors">3 packages</a> that will help you make use of our database of <strong>750+ life science investors</strong> more efficiently for your fundraise and help you discover your next medical device or health technology investor!</p><p>In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of <a href="https://medsider.com/mentors">Medsider Mentors</a> at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to <a href="https://medsider.com/subscribe">medsider.com/subscribe</a> to learn more.</p><p>Lastly, if you'd rather read than listen, <a href="https://www.medsider.com/interviews/randy-pritchard-erica-rogers-axena-health">here's a link to the full interview with Randy Pritchard and Erica Rogers.</a></p>
April 8, 2025
<p>In this episode of <a href="https://medsider.com/interviews">Medsider Radio</a>, we sat down with <a href="https://www.linkedin.com/in/ryan-rhodes-992503b0/">Ryan Rhodes</a>, CEO of<a href="https://focalone.com/"> EDAP TMS</a>. EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn’t require the use of surgery or radiation. </p><p>Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company’s entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development.</p><p>In this interview,<a href="https://www.linkedin.com/in/ryan-rhodes-992503b0/"> </a>Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.</p><p>Before we dive into the discussion, I wanted to mention a few things:</p><p>First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to <a href="https://medsider.com/">Medsider.com</a> and sign up for our free newsletter.</p><p>Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a <a href="https://medsider.com/subscribe">Medsider premium membership</a>. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!</p><p>We recently introduced some fantastic additions exclusively for Medsider premium members, including <a href="https://medsider.com/playbooks">playbooks</a>, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and <a href="https://medsider.com/investors">3 packages</a> that will help you make use of our database of <strong>750+ life science investors</strong> more efficiently for your fundraise and help you discover your next medical device or health technology investor!</p><p>In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of <a href="https://medsider.com/mentors">Medsider Mentors</a> at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to <a href="https://medsider.com/subscribe">medsider.com/subscribe</a> to learn more.</p><p>Lastly, if you'd rather read than listen, <a href="https://www.medsider.com/interviews/ryan-rhodes-edap-tms">here's a link to the full interview with Ryan Rhodes.</a></p>
April 2, 2025
<p>In this episode of <a href="https://medsider.com/interviews">Medsider Radio</a>, we sat down with <a href="https://www.linkedin.com/in/kirkhuntsman/">Kirk Huntsman</a>, CEO of <a href="https://vivos.com/patients/">Vivos</a>, a company commercializing a non-invasive, FDA-cleared oral appliance designed to treat obstructive sleep apnea (OSA).</p><p> Kirk is a seasoned healthcare entrepreneur with a track record for scaling and exiting successful businesses. He founded Dental One, growing it into one of the largest dental service organizations (DSO) in the U.S., with over 165 practices across 15 states. After selling the company to MSD Capital, he led ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. He later built and exited Xenith Practices, another DSO, and founded Ortho Ventures, focusing on pediatric oral appliances. Now as CEO of Vivos, Kirk and his team are developing and commercializing proprietary treatments for sleep-related breathing disorders, offering patients an FDA-cleared alternative to CPAP therapy.</p><p>In this interview, Kirk talks about his go-to-market strategy, the importance of credibility markers, the complexity of industry partnerships, and the challenges he faced pursuing an IPO.</p><p><br></p><p>Before we dive into the discussion, I wanted to mention a few things:</p><p>First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to <a href="https://medsider.com/">Medsider.com</a> and sign up for our free newsletter.</p><p>Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a <a href="https://medsider.com/subscribe">Medsider premium membership</a>. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!</p><p>We recently introduced some fantastic additions exclusively for Medsider premium members, including <a href="https://medsider.com/playbooks">playbooks</a>, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and <a href="https://medsider.com/investors">3 packages</a> that will help you make use of our database of <strong>750+ life science investors</strong> more efficiently for your fundraise and help you discover your next medical device or health technology investor!</p><p>In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of <a href="https://medsider.com/mentors">Medsider Mentors</a> at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to <a href="https://medsider.com/subscribe">medsider.com/subscribe</a> to learn more.</p><p>Lastly, if you'd rather read than listen, <a href="https://www.medsider.com/interviews/kirk-huntsman-vivos">here's a link to the full interview with Kirk Huntsman.</a></p>
Project Medtech
All-In Podcast, LLC
STAT
Lex Fridman
Harry Stebbings
BG2Pod
Colossus | Investing & Business Podcasts
Ben Gilbert and David Rosenthal
Healthegy
The Wall Street Journal
The Wall Street Journal
NPR
Shane Parrish
Freakonomics Radio + Stitcher
Seeking Alpha
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.